Cancer Genetics provides discovery services such as contract research services, focused primarily on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. Co. provides preclinical services such as predictive tumor models, human orthotopic xenografts and syngeneic immuno-oncology relevant tumor models. Co.'s subsidiary, vivoPharm, Pty Ltd., provides services in assessment of safety, toxicology and bioanalytic services for small and bio-molecules. Co. provides the tools and testing methods for companies and researchers seeking to identify and to develop new compounds and molecular-based biomarkers for diagnostics and therapeutics.
|
Free CGIX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |